Employing Electric Current Patents (Class 435/450)
  • Patent number: 6623964
    Abstract: The invention concerns a method for treating an aqueous flow colonized by cells with a pulsed electric field applied to a flow, characterized in that the applied field is substantially parallel to the direction of flow and to its application to the transfer of nucleic acids (RNA, DNA, oligonucleotides) into cells, to the transfer of proteins to cells, to the extraction of cytoplasmic macromolecules and molecules contained in the cells, to cell fusion and the production of hybrids and/or to insertion of membrane proteins. It also concerns an electropulsing chamber, a method for destroying cells and a membrane permeabilization method.
    Type: Grant
    Filed: October 15, 2001
    Date of Patent: September 23, 2003
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Marie-Christine Vernhes, Pierre-André René Cabanes, Justin Teissie
  • Patent number: 6586584
    Abstract: Primers and probes derived from the 5′ untranslated region of the HCV genome which facilitate detection and/or quantification of all presently known genotypes of HCV. Disclosed sequences may be used in a variety of primer and probe constructs for amplification and/or detection of HCV nucleic acids.
    Type: Grant
    Filed: January 29, 2001
    Date of Patent: July 1, 2003
    Assignee: Becton, Dickinson and Company
    Inventors: Ray A. McMillian, Tobin J. Hellyer
  • Patent number: 6531646
    Abstract: A method for the genetic modification and improvement of Porphyra species utilizing protoplast fusion is disclosed. The method of the invention features the use of conchoporangial branch conchocelis for at least one of the sources of protoplasts for protoplast fusion. Protoplasts produced from conchosporangial branch conchocelis of one species may be mixed with protoplasts produced from either blade material or conchocelis of a second species and fused using either a chemical fusing agent like polyethylene glycol (PEG) or electrofusion. Alternatively, an algal species other than a Porphyra species may be the second source of protoplasts. After fusion has occurred, fusion products are isolated and regenerated to whole plants or used as multicellular material.
    Type: Grant
    Filed: June 12, 2000
    Date of Patent: March 11, 2003
    Assignee: Northeastern University
    Inventors: Donald P. Cheney, Kathryn M. Roberts, Katherine L. Watson
  • Patent number: 6492175
    Abstract: An electroporation and/or fusion treatment of microscopic objects occurs in a medium between at least two electrodes, with the electrodes being miniaturized electrodes in a microsystem with a channel structure which is set up for the flow-through of the medium with the objects.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: December 10, 2002
    Assignee: Evotec Bio Systems AG
    Inventors: Torsten Müller, Thomas Schnelle, Günter Fuhr, Stephen Graham Shirley, Gabriele Gradl
  • Publication number: 20020061591
    Abstract: Among other things, the invention provides devices and methods for obtaining electric field-enhanced bioconjugation events. In particular, the invention provides for contactless electrodes for obtaining the electric field, such that transport and bioconjugation of charged molecules is obtained in the absence of current flow through the buffer, sample, and/or porous media.
    Type: Application
    Filed: April 19, 2001
    Publication date: May 23, 2002
    Inventors: Vi-En Choong, George Maracas, Larry Akio Nagahara
  • Patent number: 6383811
    Abstract: An polyampholyte is utilized in a condensed polynucleotide complex for purposes of nucleic acid delivery to a cell. The complex can be formed with an appropriate amount of positive and/or negative charge such that the resulting complex can be delivered to the extravascular space and may be further delivered to a cell.
    Type: Grant
    Filed: January 2, 2001
    Date of Patent: May 7, 2002
    Assignee: Mirus Corporation
    Inventors: Jon A. Wolff, James E. Hagstrom, Vladimir G. Budker, Vladimir S. Trubetskoy
  • Patent number: 6355485
    Abstract: A new and useful apparatus for producing cell electrofusion is provided. The apparatus comprises: a. a chamber with a substrate disposed therein, b. means for directing the cells to be fused toward one side of the substrate; and c. a device for inducing fusion of the portion of the cells.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: March 12, 2002
    Assignee: University of South Florida
    Inventors: Mark J. Jaroszeski, Richard A. Gilbert, Richard Heller
  • Patent number: 6333194
    Abstract: The invention relates to compositions and methods for delivering a virus vector to an animal. The compositions include compositions which comprise a hydrogel matrix (e.g. a collagen matrix which can comprise a poloxamer or an alginate) containing a virus vector therein in a transfectious form. The invention also includes methods of making such hydrogel precursor mixtures and hydrogel matrices, including particles, devices, bulk materials, and other objects which comprise, consist of, or are coated with such mixtures or matrices. The invention further relates to compositions comprising a hydrogel precursor mixture having a virus vector suspended therein, which, when administered to an animal, gel to form a hydrogel matrix containing a virus vector therein in a transfectious form. Methods of delivering a virus vector to an animal tissue are also described.
    Type: Grant
    Filed: January 19, 2000
    Date of Patent: December 25, 2001
    Assignee: The Children's Hospital of Philadelphia
    Inventors: Robert J. Levy, Timothy Crombleholme, Narendra Vyavahare
  • Patent number: 6221665
    Abstract: A new and useful apparatus for producing cell electrofusion is provided. The apparatus comprises: a. a chamber with a substrate disposed therein, b. means for directing the cells to be fused toward one side of the substrate in so that the cells in the fluid medium are retained against the one side of the substrate with a significant portion of the cells in cell-to-cell contact with each other along said one side of the substrate, and c. a device for inducing fusion of the portion of the cells in cell-to-cell contact with each other along the predetermined portion of the one side of the substrate.
    Type: Grant
    Filed: June 8, 1999
    Date of Patent: April 24, 2001
    Assignee: University of South Florida
    Inventors: Mark J. Jaroszeski, Richard A. Gilbert, Richard Heller
  • Patent number: 6143564
    Abstract: The invention provides a method for obtaining a live offspring having maternal chromosomes derived from a live first polar body of an oocyte that has completed the first meiotic division. It has been discovered herein that chromosomes in the first polar body are able to participate in normal embryonic development if they are allowed to complete the second meiotic division within an enucleated mature oocyte, and are then allowed to mingle with chromosomes of a spermatozoon. The invention further provides a method for producing up to four embyros or live offspring having the chromosomes of a single oocyte, by using both the first polar body chromosomes, and the second polar body chromosomes to reconstitute recipient enucleated (fertilized) oocytes.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: November 7, 2000
    Assignee: University of Hawaii
    Inventors: Teruhiko Wakayama, Ryuzo Yanagimachi
  • Patent number: 6107543
    Abstract: The use of totipotent embryonic stem cells to provide substantially identical cells for embryo cloning techniques is described. The method includes the culture of loose suspensions of inner cell mass cells of bovine animals to retrieve large populations of stem cells. The invention also describes the use of stem cells in various genetic manipulation techniques.
    Type: Grant
    Filed: December 2, 1994
    Date of Patent: August 22, 2000
    Assignee: Infigen, Inc.
    Inventors: Michelle M. Sims, Neal L. First
  • Patent number: 5989901
    Abstract: A computer system for controlling the parameters used during molecule transfer operations. The computer system includes a processor coupled to a memory. The memory stores instructions that are executed by the processor. The computer system controls the value of parameters that affect the characteristics of pulses delivered by a pulse generating circuit to a solution. The pulse generating unit delivers individual pulses during cycles. The cumulative pulse delivered during a specified number of cycles is a pulse output. The magnitude of a pulse output is determined by the number of cycles corresponding to the pulse output and the characteristics of the individual pulses delivered during the cycles. A pulse group is a series of pulse outputs. The computer system controls a molecule transfer operation by causing the pulse generation circuit to deliver one or more pulse groups to the solution. A user selects the shape and number of pulse groups to be delivered for an operation.
    Type: Grant
    Filed: January 12, 1998
    Date of Patent: November 23, 1999
    Inventors: Xi Zhao, Guobing Jin
  • Patent number: 5750496
    Abstract: A method for controlling infections caused by Cryptosporidium parvum. The method comprises using protease inhibiting compounds, preferably serine protease inhibitors, to inhibit excystation, invasion, and parasite maturation and development. The method is directed to therapeutic treatment of mammals, such as humans, exposed to C. parvum, and additionally as a prophylactic treatment in immunocompromised subjects at high risk for contracting cryptosporidiosis.
    Type: Grant
    Filed: August 12, 1996
    Date of Patent: May 12, 1998
    Assignee: Utah State University
    Inventors: John R. Forney, Shiguang Yang, Mark C. Healey
  • Patent number: 5686252
    Abstract: An immunochemical method is provided for the detection and determination of an analyte. The zeta potential of a latex-particle loaded with an immunologically active substance is measured before and after bringing the loaded latex-particle into contact with an analyte. The difference in zeta potential is correlated with changes of zeta potential for known concentrations of the analyte in order to determine the presence and amount of the analyte.
    Type: Grant
    Filed: October 23, 1995
    Date of Patent: November 11, 1997
    Assignee: Hoechst Japan Limited
    Inventor: Hiroshi Nishizaki